Post Subject #73   Interesting Institutional Activity: FACT-MASTER 05/15/22 10:32:39 PM #72   SCPS - Letter from Ashish Sanghrajka FACT-MASTER 05/14/22 02:14:58 PM #71   SCPS - Departure of Ashish Sanghrajka. FACT-MASTER 05/13/22 05:36:47 PM #70   SCPS - Nasdaq's Listing Rule 5550(a)(2) -minimum FACT-MASTER 05/12/22 10:06:46 PM #69   SCPS - Nasdaq’s majority independent director requirement: FACT-MASTER 05/12/22 10:02:39 PM #68   Mount Scopus FACT-MASTER 05/05/22 09:30:19 PM #67   A greeting to Dr. Raphael (Rafi) Hofstein. FACT-MASTER 05/05/22 09:05:40 PM #66   https://ih.advfn.com/stock-market/NASDAQ/scopus-biopharma-SCPS/stock-news/880213 FACT-MASTER 05/05/22 11:10:18 AM #65   https://ih.advfn.com/stock-market/NASDAQ/scopus-biopharma-SCPS/stock-news/88013525/current-report-fi FACT-MASTER 05/04/22 05:27:15 PM #64   SCPS = on track to resolution, imo. FACT-MASTER 05/02/22 06:21:13 PM #63   cont'd Delaware case FACT-MASTER 05/02/22 06:11:36 PM #62   https://ih.advfn.com/stock-market/NASDAQ/scopus-biopharma-SCPS/stock-news/87982197/amended-annual-re FACT-MASTER 05/02/22 05:55:41 PM #61   https://ih.advfn.com/stock-market/NASDAQ/scopus-biopharma-SCPS/stock-news/879673 FACT-MASTER 04/29/22 10:27:36 PM #60   https://www.clinicaltrials.gov/ct2/show/record/NCT04995536?term=scopus+biopharma&recrs=ab&co FACT-MASTER 04/23/22 09:17:06 PM #59   SCPS (120 days from Y/E is April 30/22) FACT-MASTER 04/23/22 09:11:02 PM #58   Answer: DUET-01 is in a Phase 1 clinical FACT-MASTER 04/18/22 07:58:11 PM #57   Question: Chairman Messr. Lamstein, is the phase FACT-MASTER 04/15/22 10:43:38 PM #56   Resolve the issues now please, for the greater FACT-MASTER 04/15/22 10:23:27 PM #55   In an attempt to mitigate the dispute, reduce FACT-MASTER 04/15/22 10:10:04 PM #54   13.Subsequent Events FACT-MASTER 04/15/22 10:05:27 PM #53   Cash, end of period $7,942,971 FACT-MASTER 04/15/22 09:57:41 PM #52   Remember the good ole days... FACT-MASTER 04/07/22 10:08:43 PM #51   Pivotal next few months for this company, imo. FACT-MASTER 04/02/22 10:35:42 PM #50   tsk tsk Scopus mgmt. FACT-MASTER 04/01/22 09:58:04 PM #49   They have until May2/22 to submit their "PLAN" FACT-MASTER 03/31/22 10:43:14 PM #48   NYS Court of Appeals Holds Criminally Usurious Loans FACT-MASTER 03/30/22 09:21:43 PM #47   "On October 26, 2021, Dr. Laster and Messrs. FACT-MASTER 03/30/22 09:15:48 PM #46   Let's hope that Phase I does not experience FACT-MASTER 03/29/22 09:07:47 PM #45   After some review, no,i don't think Laster is FACT-MASTER 03/29/22 09:06:22 PM #44   Watching for the following: FACT-MASTER 03/27/22 07:31:46 PM #43   Complicated, but interesting company, lotsa passion here. FACT-MASTER 03/27/22 07:14:51 PM #42   Good review here: FACT-MASTER 03/27/22 06:43:12 PM #41   Bids building into the close. FACT-MASTER 03/24/22 03:57:09 PM #40   Many high profile institutions at the conference. FACT-MASTER 03/22/22 10:41:21 PM #39   A special THANK YOU to Scopus mgmt. for FACT-MASTER 03/22/22 09:25:57 PM #38   **ATTENTION PLEASE - NEWS OUT** FACT-MASTER 03/22/22 09:18:07 PM #37   Details of the study here:(underlined is what makes FACT-MASTER 03/22/22 04:15:43 PM #36   Track the Phase I Study here: FACT-MASTER 03/22/22 04:07:50 PM #35   Go here first for checking Delaware case/search by FACT-MASTER 03/21/22 04:41:02 PM #34   Last at 0.8205 + .1812 FACT-MASTER 03/21/22 04:06:41 PM #33   Excellent information here: FACT-MASTER 03/21/22 10:53:52 AM #32   SCOPUS UN-RESOLVED CASES: FACT-MASTER 03/18/22 10:24:52 PM #31   SCOPUS RESOLVED CASES: FACT-MASTER 03/18/22 10:19:35 PM #30   Before the sun slips under the horizon this FACT-MASTER 03/18/22 02:06:56 PM #29   Real Time FACT-MASTER 03/18/22 01:50:50 PM #28   imho, summthing's up. FACT-MASTER 03/18/22 01:18:13 PM #27   AH close of .80!! FACT-MASTER 03/11/22 10:20:32 PM #26   NICE VOLUME !! coupled with a nice price uptick. FACT-MASTER 03/11/22 07:21:07 PM #25   No PM. FACT-MASTER 03/10/22 09:23:17 PM #24   Level II not looking good. FACT-MASTER 03/09/22 06:54:11 PM Post Subject

© 2022 InvestorsHub.com, Inc.